825 results on '"Ito, Tomoki"'
Search Results
2. The impact of renal function on initial therapy in transplant-ineligible multiple myeloma patients
3. Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study
4. Venetoclax treatment for chronic lymphocytic leukemia/small lymphocytic leukemia in Japan: post-marketing surveillance
5. Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis
6. Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan
7. Overexpression of NtERF5, belonging to the ethylene response factor gene family, inhibits potato virus X infection and enhances expression of jasmonic acid/ethylene signaling marker genes in tobacco
8. Correction to: Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis
9. The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients
10. Prevalence and causes of subacute cough in Japan
11. Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum
12. Prevalence and causes of chronic cough in Japan
13. Invalidity of JRS atypical pneumonia prediction score in Omicron variant of COVID-19 pneumonia
14. Is the JRS atypical pneumonia prediction score useful in detecting COVID-19 pneumonia under nursing or healthcare settings?
15. Nursing and healthcare-associated pneumonia due to SARS-CoV-2 Omicron variant
16. Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin
17. Real-world data from yttrium-90 ibritumomab tiuxetan treatment of relapsed or refractory indolent B-cell non-Hodgkin's lymphoma: J3Zi Study
18. Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
19. Deep Recurrent Factor Model: Interpretable Non-Linear and Time-Varying Multi-Factor Model
20. Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 study
21. Real-world efficacy of letermovir prophylaxis for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: A single-center retrospective analysis
22. Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapy
23. Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study
24. Analysis of HLA haplotype and clinical factors during hematopoietic stem cell transplantation
25. Decreased Proteasomal Function Induces Neuronal Loss and Memory Impairment
26. Segment Information Extraction from Financial Annual Reports Using Neural Network
27. Concept Cloud-Based Sentiment Visualization for Financial Reviews
28. Immunomodulatory drugs suppress Th1-inducing ability of dendritic cells but enhance Th2-mediated allergic responses
29. Tender Document Analyzer with the Combination of Supervised Learning and LLM-based Improver
30. Concomitant use of interleukin-2 and tacrolimus suppresses follicular helper T cell proportion and exerts therapeutic effect against lupus nephritis in systemic lupus erythematosus-like chronic graft versus host disease
31. Aspiration pneumonia was the most frequent cause of death in older patients with SARS‐CoV‐2 omicron‐related pneumonia in Japan
32. Comparison of starting doses of anagrelide as a first-line therapy in patients with cytoreductive therapy-naïve essential thrombocythemia: difference between starting at 0.5 and 1.0 mg/day
33. Contextual Sentiment Neural Network for Document Sentiment Analysis
34. GINN: gradient interpretable neural networks for visualizing financial texts
35. Effects of recombinant thrombomodulin therapy and soluble human leukocyte antigen-G levels during hematopoietic stem cell transplantation
36. An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study)
37. Long‐term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open‐label extension study following a phase 3 placebo‐controlled, double‐blind, parallel‐group study
38. Proposal of a Light Reduction Systems to Prevent Dazzling Caused by High Beam
39. Evaluation of eltrombopag in patients with aplastic anemia in real-world experience
40. 輸血症例から検出された同種抗体様mimicking抗cと免疫刺激のない症例から検出された自己抗体様mimicking抗E
41. Text-Visualizing Neural Network Model: Understanding Online Financial Textual Data
42. Crystal growth and scintillation properties of Pr-doped SrI2 single crystals
43. Chitosan gel sheet containing drug carriers with controllable drug-release properties
44. Extraction of Bi-graph Structures Among Multilingual Financial Words Using Text-Mining Methods
45. Comparison of pneumonia severity scores for COVID-19 patients with the Omicron variant
46. Overexpression of NtERF5, belonging to the ethylene response factor gene family, inhibits potato virus X infection and enhances expression of jasmonic acid/ethylene signaling marker genes in tobacco
47. Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
48. Efficacy of Gefapixant, a P2X3 Antagonist, for Refractory Atopic Cough
49. Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation
50. Dual drug release from hydrogels covalently containing polymeric micelles that possess different drug release properties
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.